Señales en vivo de 002880.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 03:04):

Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications...

Stats
Volumen de hoy	4.52M
Volumen promedio	1.32M
Capitalización de mercado	7.41B
EPS	CNY0.221 ( 2023-10-25 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	33.67
ATR14	CNY0.134 (0.41%)

Volumen Correlación

Largo: 0.46 (neutral)

Corto: -0.39 (neutral)

Signal:(52.366) Neutral

Shenzhen Weiguang Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shenzhen Weiguang Correlación - Moneda/Commodity

0.06
( neutral )

-0.55
( weak negative )

0.00
( neutral )

-0.13
( neutral )

-0.04
( neutral )

-0.57
( weak negative )

Shenzhen Weiguang Finanzas

Annual	2023
Ingresos:	CNY1.05B
Beneficio Bruto:	CNY433.24M (41.32 %)
EPS:	CNY0.960

FY	2023
Ingresos:	CNY1.05B
Beneficio Bruto:	CNY433.24M (41.32 %)
EPS:	CNY0.960

FY	2022
Ingresos:	CNY667.93M
Beneficio Bruto:	CNY240.91M (36.07 %)
EPS:	CNY0.520

FY	2021
Ingresos:	CNY907.43M
Beneficio Bruto:	CNY370.91M (40.87 %)
EPS:	CNY0.906

Financial Reports:

No articles found.

Shenzhen Weiguang